Active ingredientTiboloneCat. No. P-T111-001CAS 5630-53-5Family · Pharmaceutical analytical standards
Tibolone
A synthetic steroid with weak oestrogenic, progestogenic and androgenic activity, developed in the 1960s and introduced in the Netherlands in 1988: it is used in menopausal hormone therapy and against postmenopausal osteoporosis. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?In the body it turns into metabolites with different actions: two hydroxy derivatives act as oestrogens, while delta-4-tibolone has progestogenic and androgenic effects.
Go to the active ingredient →Active ingredientTiboloneCat. No. P-T111-001CAS 5630-53-5
Pharmacopoeial impurityTibolone EP Impurity ACat. No. P-T111-002CAS 105186-35-4
Pharmacopoeial impurityTibolone EP Impurity BCat. No. P-T111-003CAS 105186-34-3
Pharmacopoeial impurityTibolone EP Impurity CCat. No. P-T111-004CAS 1162-60-3
Pharmacopoeial impurityTibolone EP Impurity DCat. No. P-T111-005CAS 32297-45-3
Pharmacopoeial impurityTibolone EP Impurity ECat. No. P-T111-006CAS 105186-33-2
Impurity3alpha-HydroxytiboloneCat. No. P-T111-007CAS 100239-44-9
Impurity3beta-HydroxytiboloneCat. No. P-T111-008CAS 100239-45-0
ImpurityTibolone Impurity 1Cat. No. P-T111-009CAS 88247-84-1
ImpurityTibolone Impurity 2Cat. No. P-T111-010CAS 1173998-66-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceTibolone CRSEDQM code Y0002348Family TiboloneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.